diabetes medication

Tirzepatide, marketed under the brand name Mounjaro, is a novel medication designed for the treatment of type 2 diabetes. It functions as a dual GIP and GLP-1 receptor agonist, which means it targets two key hormones involved in glucose regulation and appetite control. By stimulating insulin secretion and mitigating glucagon release, tirzepatide not only helps…